| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 05/06/2009 | EP2054894A2 Composition apparatus and method for use in imaging |
| 05/06/2009 | EP2054165A2 Method of covering self-assembled metal or inorganic monolayer surfaces of gem-bisphosphonic compounds and uses thereof |
| 05/06/2009 | EP2054087A2 Polychromatic, diversely-sized particles for angiography |
| 05/06/2009 | EP1679960B1 Transgenic amphibian models for lymphatic vessel development |
| 05/06/2009 | EP1410022B1 Detection and treatment of prostate cancer |
| 05/06/2009 | EP1385480B1 Liposomes |
| 05/06/2009 | EP1343770B1 Lithium complexes of n-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, production and use thereof |
| 05/06/2009 | CN101423546A Radioactive rhenium marked polypeptide containing RGD sequence as well as preparation method and application thereof |
| 05/06/2009 | CN101422622A B-ultrasonic traditional Chinese medicine imaging assistant and preparation method thereof |
| 05/06/2009 | CN101422621A Method for the production of bio-imaging nanoparticles with high yield by early introduction of irregular structure |
| 05/06/2009 | CN101422388A Production method of blood-stasis characterization module and use of blood-stasis characterization module |
| 05/06/2009 | CN100484495C Mouse asthmatic model semiotic monitor |
| 05/05/2009 | US7528108 Administering zinc-charged, protease-digested protein (derived, for example, from serum or milk) and carrier, excipient or diluent; induces apoptosis of an adipocyte; non-invasive weight loss treatment that would act by reducing the number of fat cells |
| 05/05/2009 | US7527973 Monoclonal antibody or an antigen binding fragment that specifically binds amino acids of a West Nile virus E protein |
| 05/05/2009 | US7527809 Polyhydroxyalkanoate-containing magnetic structure, and manufacturing method and use thereof |
| 05/05/2009 | US7527783 Subcutaneous injection of allergens ( pollen, mold, pet dander, dust mite, cockroach) that had been treated with ahypohalous acid, ahypohalous acid salt, for in vivo testing allergic response |
| 04/30/2009 | WO2009054958A2 Metallofullerene contrast agents |
| 04/30/2009 | WO2009054853A1 Loadable polymeric particles for cosmetic and reconstructive tissue augmentation applications and methods of preparing and using the same |
| 04/30/2009 | WO2009054608A1 Water soluble photochromic compounds for labeling of biomolecules and method for detecting biomolecules using the same |
| 04/30/2009 | WO2009054558A1 A method for diagnosing disease using adenovirus harboring trans-splicing ribozyme by molecular imaging |
| 04/30/2009 | WO2009054497A1 Novel compound having affinity for amyloid |
| 04/30/2009 | WO2009054496A1 Novel compound having affinity for amyloid |
| 04/30/2009 | WO2009054455A1 Hyperbranched polymer having nitroxyl group |
| 04/30/2009 | WO2009054327A1 Mri probe |
| 04/30/2009 | WO2009053876A2 Nir emitters excitable in the visible spectral range and their application in biochemical and medical imaging |
| 04/30/2009 | WO2009053597A2 Novel method for preparing nanoparticles covered with an organic stabilising layer coupled to targeting ligands |
| 04/30/2009 | WO2009053596A2 Novel method for preparing nanoparticles covered with a gem-bisphosphonate stabilising layer coupled to hydrophilic biodistribution ligands |
| 04/30/2009 | WO2009053372A2 Bone substitute containing a contrast agent, method for preparing same and uses thereof |
| 04/30/2009 | WO2009032752A3 Multimodal nanoparticles for non-invasive bio-imaging |
| 04/30/2009 | WO2008094834A3 Multi-functional drug carriers |
| 04/30/2009 | WO2008048271A3 Polymer coated microparticles |
| 04/30/2009 | WO2008005514A3 Polychromatic, diversely-sized particles for angiography |
| 04/30/2009 | WO2007044963A3 Development of prodrugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety using in vitro/in silico predictions |
| 04/30/2009 | WO2007041283A3 Maternal chelation for embryo, fetal, and infant benefit |
| 04/30/2009 | WO2006119438A3 Methods for measuring cholesterol metabolism and transport |
| 04/30/2009 | US20090113565 Methods for Detecting Fluorescent Proteins and Animals Having Fluorescent Proteins |
| 04/30/2009 | US20090112022 Preparation of iodixanol |
| 04/30/2009 | US20090110644 Polymer nanoparticles coated by magnetic metal oxide and uses thereof |
| 04/30/2009 | US20090110642 Method for the production of bio-imaging nanoparticles with high yield by early introduction of irregular structure |
| 04/30/2009 | US20090110640 Contrast agents for magnetic resonance imaging and spectroscopy consisting of a cyclic oligoamid core of 3 to 4 identicial monomer units with 3 to 4 paramagnetic chelate side chains |
| 04/30/2009 | US20090110639 Predicting vaccine efficacy |
| 04/30/2009 | US20090110638 Methods using the grueneberg ganglion chemosensory system |
| 04/30/2009 | US20090110637 LMP and Regulation of Tissue Growth |
| 04/30/2009 | DE102008047781A1 Use of an oligopeptide comprising a specific amino acid-sequence for the diagnosis or therapy of a pathological condition in a mammal, preferably human, where the condition is identified by angiogenic processes |
| 04/30/2009 | CA2704027A1 Novel compound having affinity for amyloid |
| 04/30/2009 | CA2703649A1 Novel compound having affinity for amyloid |
| 04/30/2009 | CA2703469A1 Metallofullerene contrast agents |
| 04/30/2009 | CA2701908A1 Bone substitute containing a contrast agent, method for preparing same and uses thereof |
| 04/30/2009 | CA2675342A1 A method for diagnosing disease using adenovirus harboring trans-splicing ribozyme by molecular imaging |
| 04/29/2009 | EP2053409A1 Specific markers for metabolic syndrome |
| 04/29/2009 | EP2053129A2 Method of diagnosing, monitoring, staging, imaging and treating various cancers |
| 04/29/2009 | EP2051739A2 Imaging medium comprising lactate and hyperpolarised 13c-pyruvate |
| 04/29/2009 | EP1786475B1 1,4-bis(carboxymethyl)-6-[bis(carboxymethyl)amino]-6-methyl-perhydro-1,4-diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri) |
| 04/29/2009 | EP1765812B1 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents |
| 04/29/2009 | EP1601392B1 Compositions for use in embolizing blood vessels comprising high levels of contrast agent |
| 04/29/2009 | EP1299718A4 Radio-opaque polymeric compositions |
| 04/29/2009 | EP1265640B1 Fluorescent membrane intercalating probes and methods for their use |
| 04/29/2009 | CN101421323A Loaded latex optical molecular imaging probes |
| 04/29/2009 | CN101420985A Test agent for diagnosing dyspepsia |
| 04/29/2009 | CN100482278C Micro-cluster liquids and methods of making and using them |
| 04/28/2009 | US7524517 Methods and compositions for P2X receptor calcium entry channels and other calcium entry mechanisms |
| 04/28/2009 | US7524483 Responsive paramagnetic MRI contrast agents |
| 04/28/2009 | CA2425704C Tissue-specific exogenous optical agents |
| 04/28/2009 | CA2279530C A method for the detection and localization of ductal exocrine pancreas tumours |
| 04/23/2009 | WO2009051599A1 Use of biomarkers of alzheimer's disease for diagnostic tests and drug screening |
| 04/23/2009 | WO2009051016A1 Silicon quantum dots and biological labeling agent using the same |
| 04/23/2009 | WO2009050447A2 Water-based skin products |
| 04/23/2009 | WO2009049913A1 Markers of matrix gene expression and cellular differentiation in chondrocytes |
| 04/23/2009 | WO2009027388A3 Imaging medium comprising hyperpolarised 13c-acetate and use thereof |
| 04/23/2009 | WO2009013350A3 Imaging medium comprising hyperpolarised 13 c-lactate and use thereof |
| 04/23/2009 | WO2008141107A3 Compositions that include a hydrophobic compound and a polyamino acid conjugate |
| 04/23/2009 | WO2007011834A3 Compounds and method for the diagnosis and treatment of amyloid associated diseases |
| 04/23/2009 | WO2007008588A3 Omeprazole form b |
| 04/23/2009 | WO2006116538A3 Medical device with a marker |
| 04/23/2009 | WO2006052821A3 Compositions and methods for treatment of protein misfolding and protein aggregation diseases |
| 04/23/2009 | US20090104189 Neutrokine-alpha and neutrokine-alpha splice variant |
| 04/23/2009 | US20090104124 Paramagnetic Complexes with Pendant Crown Compounds Showing Improved Targeting- Specificity as MRI Contrast Agents |
| 04/23/2009 | US20090104123 Targeted contrast agents and methods for targeting contrast agents |
| 04/23/2009 | US20090104121 Multi-subunit biological complexes for treatment of plaque-associated diseases |
| 04/23/2009 | US20090104120 Dlx1 cancer markers |
| 04/23/2009 | US20090104119 Dendrimer Based Compositions And Methods Of Using The Same |
| 04/23/2009 | US20090104118 Contrast agents for myocardial perfusion imaging |
| 04/23/2009 | US20090104117 Compositions and methods of use of targeting peptides against placenta and adipose tissues |
| 04/23/2009 | US20090104116 Compounds for the inhibition of integrins and use thereof |
| 04/23/2009 | US20090104114 Nanotherapeutic Colloidal Metal Compositions and Methods |
| 04/23/2009 | US20090101806 Vessel for Rare Gas Filling, and Method for Polarization of Rare Gas Atomic Nucleus Using Said Vessel |
| 04/23/2009 | DE102007050673A1 New hexaaza-acene compounds comprising three pyrazine-annelated and additional benzo-annelated rings, useful as fluorescence dye in biochemical medical diagnostics, and as transistor in organic semiconductor technology |
| 04/23/2009 | CA2702376A1 Markers of matrix gene expression and cellular differentiation in chondrocytes |
| 04/22/2009 | EP2050470A1 Ct negative contrast medium of aqueous matrix for digestive tract and the preparation method thereof |
| 04/22/2009 | EP2050469A1 Diagnostic agent |
| 04/22/2009 | EP1531874B1 Embolic particles |
| 04/22/2009 | EP1379873B1 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 04/22/2009 | CN101415446A Method to produce hyperpolarised carboxylates and sulphonates |
| 04/22/2009 | CN100479862C Transporters and drug delivery system by using the same |
| 04/21/2009 | US7521419 Peptide-based compounds |
| 04/21/2009 | US7521416 D-amino acid peptides |
| 04/21/2009 | US7521041 Biphenyl-2-ylcarbamic acid or biphenyl-2-yluurea derivatives for treatment of respiratory system disorders; chronic obstructive pulmonary disease, asthma; antihistamines, bronchodilator agents; side effect reduction |
| 04/21/2009 | US7521040 Immunotherapy for humans |
| 04/21/2009 | CA2382641C Viscosity-standardised compositions which facilitate swallowing in dysphagic subjects |
| 04/16/2009 | WO2009047655A2 Phase change visual indicating composition |